Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DOMAR CAPSULE 5 mg - HSA Drug Approval Details

Approvals/HSA/DOMAR CAPSULE 5 mg

Approved

THERAPEUTIC

DOMAR CAPSULE 5 mg

POLIPHARM CO LTD (THAILAND)🇸🇬 Health Sciences Authority

Approval Date: May 11, 1988
Approval ID: ac2b292e39d7f80e
Company: POLIPHARM CO LTD (THAILAND)
Type: Therapeutic

Approval Details

Approval Id: ac2b292e39d7f80e
Drug Name: DOMAR CAPSULE 5 mg
Product Name: DOMAR CAPSULE 5 mg
Approval Number: SIN01038P
Approval Date: 1988-05-11
Registrant: EURODRUG LABORATORIES SINGAPORE PTE. LTD.
Licence Holder: EURODRUG LABORATORIES SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: N05BA14
Atc Item Name: pinazepam
Pharma Manufacturer Name: EURODRUG LABORATORIES SINGAPORE PTE. LTD.

Active Ingredients

PINAZEPAM

5 mg

PINAZEPAM

5 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

May 11, 1988

Approval ID

ac2b292e39d7f80e

Type

Therapeutic

Back to HSA Approvals